| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 58 companies in the Health Care Technology industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 22, 2024 | HSTM Healthstream Inc | Fenstermacher Scott45 | Senior Vice President | Sell | 1,000 | $26.59 | $26,589.50 | -6.7% | +1.9% | +22.8% | |
| Feb 21, 2024 | MSPR Msp Recovery, Inc. | Cano Health, Inc.92 | 10% Owner | Sell | 225,252 | $0.83 | $186,463.89 | -1.5% | -14.0% | -88.2% | |
| Feb 20, 2024 | TDOC Teladoc Health, Inc. | Trencher Daniel85 | Chief Strategy Officer | Sell | 1,000 | $20.64 | $20,640.00 | -5.6% | -40.0% | -32.8% | |
| Feb 20, 2024 | CERT Certara, Inc. | Smith Patrick F65 | President, Drug Dev Solutions | Sell | 5,000 | $18.00 | $90,000.00 | -8.3% | -5.6% | -19.0% | |
| Feb 20, 2024 | DOGP Dogecoin Cash, Inc. | Tankson Robert N. III | Director | Buy | 667,032 | $0.01 | $9,479.72 | +44.8% | - | - | |
| Feb 16, 2024 | DOCS Doximity, Inc. | Overpeck Craig | See Remarks | Sell | 1,500 | $30.02 | $45,030.00 | -1.3% | -21.7% | +154.1% | |
| Feb 15, 2024 | TXG 10x Genomics, Inc. | Saxonov Serge80 | Chief Executive Officer | Sell | 5,000 | $48.87 | $244,332.16 | -0.3% | -45.1% | -74.4% | |
| Feb 15, 2024 | HCAT Health Catalyst, Inc. | Llewelyn Linda82 | Chief People Officer | Sell | 3,262 | $9.77 | $31,854.73 | -4.8% | -32.4% | -46.0% | |
| Feb 15, 2024 | MSPR Msp Recovery, Inc. | Cano Health, Inc.92 | 10% Owner | Sell | 221,246 | $0.79 | $174,274.54 | -1.4% | -3.8% | -86.2% | |
| Feb 12, 2024 | SDGR Schrodinger, Inc. | Tran Yvonne82 | EVP, CLO &CPO | Sell | 758 | $28.29 | $21,443.82 | -6.0% | -18.7% | -14.1% | |
| Feb 12, 2024 | CERT Certara, Inc. | Traynor Richard M.80 | SVP And General Counsel | Sell | 6,000 | $18.00 | $108,000.00 | -3.5% | -6.9% | -22.5% | |
| Feb 12, 2024 | SDGR Schrodinger, Inc. | Abel Robert Lorne80 | See Remarks | Sell | 1,205 | $27.55 | $33,197.75 | -11.4% | -18.7% | -14.1% | |
| Feb 12, 2024 | SDGR Schrodinger, Inc. | Lorton Kenneth Patrick74 | EVP, CTO &COO, Software | Sell | 901 | $28.29 | $25,489.29 | -2.4% | -18.7% | -14.1% | |
| Feb 12, 2024 | SDGR Schrodinger, Inc. | Herman Jenny65 | SVP &Controller | Sell | 787 | $28.29 | $22,264.23 | -6.3% | -18.7% | -14.1% | |
| Feb 12, 2024 | MSPR Msp Recovery, Inc. | Cano Health, Inc.92 | 10% Owner | Sell | 124,923 | $0.78 | $97,809.64 | -0.8% | +5.1% | -85.9% | |
| Feb 9, 2024 | PHR Phreesia, Inc. | Gunzburg Janet50 | Principal Accounting Officer | Sell | 480 | $28.00 | $13,440.00 | -1.2% | -21.3% | +3.8% | |
| Feb 9, 2024 | HQY Healthequity, Inc. | Ladd Delano51 | EVP, GC &Corporate Secretary | Sell | 2,499 | $80.00 | $199,920.00 | -4.8% | -2.7% | +40.1% | |
| Feb 9, 2024 | TXG 10x Genomics, Inc. | Saxonov Serge80 | Chief Executive Officer | Sell | 1,000 | $49.53 | $49,530.10 | -0.1% | -46.7% | -71.2% | |
| Feb 7, 2024 | MSPR Msp Recovery, Inc. | Cano Health, Inc.92 | 10% Owner | Sell | 200,057 | $0.82 | $164,536.82 | -1.2% | +7.1% | -85.8% | |
| Feb 6, 2024 | FOXO Foxo Technologies Inc. | White Mark Brian | Interim CEO | Sell | 250,000 | $0.42 | $105,000.00 | -100% | - | - | |
| Feb 6, 2024 | FOXO Foxo Technologies Inc. | Ward Martin Christopher | Interim CFO | Sell | 250,000 | $0.42 | $105,000.00 | -100% | - | - | |
| Feb 5, 2024 | VEEV Veeva Systems Inc | Wallach Matthew J58 | Director | Sell | 5,000 | $203.43 | $1,017,146.68 | -1.2% | -0.5% | +14.3% | |
| Feb 2, 2024 | PHR Phreesia, Inc. | Gunzburg Janet50 | Principal Accounting Officer | Sell | 480 | $27.00 | $12,960.00 | -1.2% | -16.7% | +6.6% | |
| Feb 2, 2024 | TDOC Teladoc Health, Inc. | Waters Michael Willem74 | Chief Operating Officer | Sell | 4,523 | $19.18 | $86,742.09 | -10.5% | -34.4% | -48.7% | |
| Feb 2, 2024 | TDOC Teladoc Health, Inc. | Kornwasser Laizer73 | President, Enterprise Growth | Sell | 7,882 | $19.18 | $151,161.00 | -12.1% | -34.4% | -48.7% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.